Jean-Manasse Theagene - Mar 31, 2023 Form 4 Insider Report for MAIA Biotechnology, Inc. (MAIA)

Role
Director
Signature
/s/ Jean-Manasse Theagene
Stock symbol
MAIA
Transactions as of
Mar 31, 2023
Transactions value $
$0
Form type
4
Date filed
4/4/2023, 06:30 AM
Previous filing
Mar 23, 2023
Next filing
Jul 5, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MAIA Stock Options Award $0 +945 $0.00 945 Mar 31, 2023 Common Stock 945 $3.46 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options, granted on March 31, 2023 pursuant to MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date.